Savers Value Village GC Exercises & Sells Stock; Keeps Majority Options

Rhea-AI Filing Summary

On 08/04/2025, Savers Value Village (SVV) General Counsel Richard A. Medway exercised 15,000 employee stock options at an exercise price of $1.41 and immediately sold the same number of shares at $11.48 under a pre-arranged Rule 10b5-1 trading plan adopted 03/10/2025. The gross spread of roughly $151 k (before taxes/fees) was realized, and Medway now holds 0 directly owned common shares.

Post-transaction, he retains 434,256 unexercised options granted under the 2019 Management Incentive Plan. Approximately 26 % are fully vested time-based options; the remaining 74 % are performance-based, with future vesting tied to stock-price and other criteria. The option block expires 06/12/2029.

The sale represents a modest liquidity event rather than a broad insider exodus and leaves substantial incentive-aligned exposure outstanding. Investors may view the trade as neutral to slightly negative given the reduction in direct share ownership, tempered by the insider’s continued leverage to upside through sizable option holdings.

Positive

• Large remaining option position (434,256 units) keeps insider economically aligned with future performance.

Negative

• Complete disposal of 15,000 common shares reduces direct ownership and could be perceived as modestly bearish.

Insights

Securities Analyst

TL;DR: Small Rule 10b5-1 sale; insider still holds 434k options, so alignment intact—market impact likely minimal.

The transaction nets roughly $151 k for Medway and removes 15 k shares from his direct stake. Given SVV’s public float (not disclosed here but assumed to be millions of shares), the sale is immaterial. Continued ownership of over 434 k options, mostly performance-based, preserves incentive alignment and signals potential upside participation. I classify the filing as routine with limited trading-signal value.

Corporate Governance Expert

TL;DR: Pre-planned sale under 10b5-1 reduces optics risk; insider keeps large option exposure—neutral governance implications.

The use of a Rule 10b5-1 plan provides a compliance shield against accusations of opportunistic trading, enhancing transparency. Direct holdings drop to zero, which some investors might flag, yet the sizeable option balance maintains economic interest through 2029. No red flags on governance; insider trading policies appear followed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Medway Richard A.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2025		M		15,000	A	$1.41	15,000	D
Common Stock	08/04/2025		S(1)		15,000	D	$11.48	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(2)	$1.41	08/04/2025		M			15,000	(3)	06/12/2029	Common Stock	15,000	$1.41	434,256(4)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025.

2. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

3. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.

4. Approximately 26% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 74% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many SVV shares did the insider sell?

15,000 common shares were sold on 08/04/2025 at $11.48 each.

Was the sale part of a 10b5-1 trading plan?

Yes. The filing states the transaction occurred under a Rule 10b5-1 plan adopted on 03/10/2025.

What exercise price was paid for the options?

The options were exercised at $1.41 per share.

How many options does Richard Medway still hold after the transaction?

He retains 434,256 unexercised options expiring 06/12/2029.

Does the insider now own any SVV common stock directly?

No. Direct common share ownership is reported as 0 following the sale.

Are the remaining options subject to performance conditions?

Yes. About 74 % are performance-based, vesting upon meeting stock-price and other targets.